Drug Trial Radar · NCT05949684
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
402
Actual
Start
Oct 24, 2023
Primary completion
Mar 24, 2028
Study completion May 30, 2031
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jul 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to IPSS-R very low, low, intermediate-risk MDS in ESA-naïve participants who are non-transfusion dependent (NTD).
Conditions
- Myelodysplastic Syndromes
Interventions
LuspaterceptBiological
Specified dose on specified days
Epoetin AlfaBiological
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with lower-risk non-transfusion dependent myelodysplastic syndromes (NTD-MDS) who converted to Transfusion Dependence (TD) during any continuous 16-week interval within the 96-week treatment periodTime frame: Up to Week 96
- Number of participants with an increase from baseline in mean Hb values of ≥ 1.5 grams/deciliter (g/dL) in any continuous 16-week interval within the 48 week Treatment Period in the absence of transfusionTime frame: Up to Week 48
Locations
144 sites in 19 countries. Site status is shown where the registry gives one.
Local Institution - 0070
Clovis, California
Local Institution - 0179
Fountain Valley, California
Local Institution - 0211
Los Alamitos, California
Local Institution - 0258
Los Angeles, California
Local Institution - 0247
Orange, California
Local Institution - 0209
Oxnard, California
Local Institution - 0183
Walnut Creek, California
Local Institution - 0227
Hartford, Connecticut
Local Institution - 0173
New Haven, Connecticut
Halifax Health Medical Center
Daytona Beach, Florida
Local Institution - 0202
Fort Myers, Florida
Local Institution - 0180
Jacksonville, Florida
Local Institution - 0224
Margate, Florida
Local Institution - 0163
Plantation, Florida
Local Institution - 0201
St. Petersburg, Florida
Local Institution - 0238
Tamarac, Florida
Local Institution - 0106
Tampa, Florida
Local Institution - 0240
Honolulu, Hawaii
Local Institution - 0272
Chicago, Illinois
Local Institution - 0184
Skokie, Illinois
Local Institution - 0270
Dyer, Indiana
Local Institution - 0191
Baton Rouge, Louisiana
Local Institution - 0044
Covington, Louisiana
Local Institution - 0007
Bethesda, Maryland
Local Institution - 0222
Saint Louis Park, Minnesota
Local Institution - 0128
Hattiesburg, Mississippi
Local Institution - 0212
Hackensack, New Jersey
Local Institution - 0206
Columbus, Ohio
Local Institution - 0174
Knoxville, Tennessee
Local Institution - 0228
Houston, Texas
Local Institution - 0236
Richmond, Virginia
Local Institution - 0229
Roanoke, Virginia
Local Institution - 0203
Kennewick, Washington
Local Institution - 0010
Buenos Aires, Argentina
Local Institution - 0009
Buenos Aires, Argentina
Local Institution - 0012
Buenos Aires, Argentina
Local Institution - 0071
Blacktown, New South Wales, Australia
Local Institution - 0113
Camperdown, New South Wales, Australia
Local Institution - 0254
Coffs Harbour, New South Wales, Australia
Local Institution - 0246
Gold Coast, Queensland, Australia
Showing 40 of 144 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.